What's Behind a Cure?
The Research Leads to Cures Initiative
Dr. Gail J. Roboz, associate professor of medicine and director of the Leukemia Program at Weill Cornell Medical College, has seen firsthand how breakthrough research can change the lives of her patients.
"There are two subtypes of leukemia — Chronic Myeloid Leukemia (CML) and Acute Promyelocytic Leukemia (APL) — that have now gone from deadly to curable. And those transitions have been because of incredible interaction between basic scientists and clinicians," says Dr. Roboz.
In her clinical practice, Dr. Roboz treats patients of all ages with leukemia, myelodysplastic syndrome, and related blood disorders. In addition to developing and implementing clinical trials, she provides her patients with compassionate care based on the latest research advances — some of which come straight from laboratories at Weill Cornell.
"One problem with leukemias is that the molecular abnormalities are more heterogeneous — there's a lot going on," says Dr. Roboz. "In order to crack the rest of these codes, there needs to be constant interaction between the scientists and the clinicians, which has been established incredibly effectively at Weill Cornell."
Learn more about Dr. Roboz's work — in her own words — here.
Dr. Roboz and other Weill Cornell physicians are consistently making great advances in understanding, treating, and preventing cancer and a host of other debilitating diseases. These researchers are the heart of the Research Leads to Cures initiative — a new and critical phase of the Discoveries that Make a Difference campaign.
Powered by Big Medium™
